StockData
AEON Biopharma, Inc. logo

AEON Biopharma, Inc. (AEON) stock

AEONNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.12+0.01 (+9.61%)

Close on Nov 18, 2026Market cap $6.20MP/E –Yield –

AEON Biopharma shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

AEON Biopharma's shares outstanding was 51M at Jun 30, 2026. For fiscal 2025 it was 10M, up 1622.7% from the year before.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202510M+1622.7%
FY2024Dec 31, 20241M-70.1%
FY2022Dec 31, 20222M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202651M+355.6%
Q1 FY2026Mar 31, 202641M+919.2%
Q4 FY2025Dec 31, 202513M+2118.4%
Q3 FY2025Sep 30, 202512M+2018.6%
Q2 FY2025Jun 30, 202511M+1954.5%
Q1 FY2025Mar 31, 20254M+669.4%
Q4 FY2024Dec 31, 20241M-69.9%
Q3 FY2024Sep 30, 20241M-71.5%
Q2 FY2024Jun 30, 20241M-72.0%
Q1 FY2024Mar 31, 20241M-73.1%
Q2 FY2023Jun 30, 20232M–
Q1 FY2023Mar 31, 20232M–
Q4 FY2022Dec 31, 20222M–
Q3 FY2022Sep 30, 20222M–

More AEON Biopharma figures

See a number that looks wrong?